CORRECTION: Versigent Raises FY2026 Sales Guidance from $9.100B-$9.400B to $9.400B-$9.600B vs $9.286B Est
Versigent (NYSE:VGNT) raises FY2026 sales outlook from $9.100 billion-$9.400 billion to $9.400 billion-$9.600 billion vs $9.286 billion estimate.
Versigent thinks it will make more money next year than it said before, which is a good sign. When a company raises its guess about future sales, it usually means business is going well and leaders feel confident.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.